Global Genome Editing / Genome Engineering Market Overview:
Global Genome Editing / Genome Engineering Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Genome Editing / Genome Engineering Market Report 2025 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Genome Editing / Genome Engineering involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Genome Editing / Genome Engineering Market:
The Genome Editing / Genome Engineering Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Genome Editing / Genome Engineering Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Genome Editing / Genome Engineering Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Genome Editing / Genome Engineering market has been segmented into:
CRISPR
ZFN
TALEN
Other Technologies
By Application, Genome Editing / Genome Engineering market has been segmented into:
Ex-Vivo
In-Vivo
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Genome Editing / Genome Engineering market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Genome Editing / Genome Engineering market.
Top Key Players Covered in Genome Editing / Genome Engineering market are:
CRISPR Therapeutics AG
Editas Medicine Inc.
GenScript Biotech Corporation
Horizon Discovery Group PLC
Integrated DNA Technologies (IDT) Inc.
Lonza Group AG
Merck & Co. Inc.
New England Biolabs Inc.
OriGene Technologies Inc.
Sangamo Therapeutics
Thermo Fisher Scientific Inc.
Transposagen Biopharmaceuticals Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Genome Editing / Genome Engineering Market Type
4.1 Genome Editing / Genome Engineering Market Snapshot and Growth Engine
4.2 Genome Editing / Genome Engineering Market Overview
4.3 CRISPR
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 CRISPR: Geographic Segmentation Analysis
4.4 ZFN
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 ZFN: Geographic Segmentation Analysis
4.5 TALEN
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 TALEN: Geographic Segmentation Analysis
4.6 Other Technologies
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Other Technologies: Geographic Segmentation Analysis
Chapter 5: Genome Editing / Genome Engineering Market Application
5.1 Genome Editing / Genome Engineering Market Snapshot and Growth Engine
5.2 Genome Editing / Genome Engineering Market Overview
5.3 Ex-Vivo
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Ex-Vivo: Geographic Segmentation Analysis
5.4 In-Vivo
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 In-Vivo: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Genome Editing / Genome Engineering Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 CRISPR THERAPEUTICS AG; EDITAS MEDICINE
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC.; GENSCRIPT BIOTECH CORPORATION; HORIZON DISCOVERY GROUP PLC; INTEGRATED DNA TECHNOLOGIES (IDT)
6.4 INC.; LONZA GROUP AG; MERCK & CO.
6.5 INC.; NEW ENGLAND BIOLABS
6.6 INC.; ORIGENE TECHNOLOGIES
6.7 INC.; SANGAMO THERAPEUTICS; THERMO FISHER SCIENTIFIC
6.8 INC.; TRANSPOSAGEN BIOPHARMACEUTICALS
6.9 INC.
Chapter 7: Global Genome Editing / Genome Engineering Market By Region
7.1 Overview
7.2. North America Genome Editing / Genome Engineering Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 CRISPR
7.2.2.2 ZFN
7.2.2.3 TALEN
7.2.2.4 Other Technologies
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Ex-Vivo
7.2.3.2 In-Vivo
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Genome Editing / Genome Engineering Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 CRISPR
7.3.2.2 ZFN
7.3.2.3 TALEN
7.3.2.4 Other Technologies
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Ex-Vivo
7.3.3.2 In-Vivo
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Genome Editing / Genome Engineering Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 CRISPR
7.4.2.2 ZFN
7.4.2.3 TALEN
7.4.2.4 Other Technologies
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Ex-Vivo
7.4.3.2 In-Vivo
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Genome Editing / Genome Engineering Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 CRISPR
7.5.2.2 ZFN
7.5.2.3 TALEN
7.5.2.4 Other Technologies
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Ex-Vivo
7.5.3.2 In-Vivo
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Genome Editing / Genome Engineering Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 CRISPR
7.6.2.2 ZFN
7.6.2.3 TALEN
7.6.2.4 Other Technologies
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Ex-Vivo
7.6.3.2 In-Vivo
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Genome Editing / Genome Engineering Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 CRISPR
7.7.2.2 ZFN
7.7.2.3 TALEN
7.7.2.4 Other Technologies
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Ex-Vivo
7.7.3.2 In-Vivo
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Genome Editing / Genome Engineering Scope:
|
Report Data
|
Genome Editing / Genome Engineering Market
|
|
Genome Editing / Genome Engineering Market Size in 2025
|
USD XX million
|
|
Genome Editing / Genome Engineering CAGR 2025 - 2032
|
XX%
|
|
Genome Editing / Genome Engineering Base Year
|
2024
|
|
Genome Editing / Genome Engineering Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
CRISPR Therapeutics AG, Editas Medicine Inc., GenScript Biotech Corporation, Horizon Discovery Group PLC, Integrated DNA Technologies (IDT) Inc., Lonza Group AG, Merck & Co. Inc., New England Biolabs Inc., OriGene Technologies Inc., Sangamo Therapeutics, Thermo Fisher Scientific Inc., Transposagen Biopharmaceuticals Inc..
|
|
Key Segments
|
By Type
CRISPR
ZFN
TALEN
Other Technologies
By Applications
Ex-Vivo
In-Vivo
|
